Toll-like receptors: emerging targets of immunomodulation

Author： Quesniaux Valerie FJ   Ryffel Bernhard  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.1, 2004-01, pp. : 85-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Toll-like receptors (TLRs) were shown to play a critical role in the recognition and activation of pathogens by the innate immune system. Pathogen engagement of the TLR–myeloid differentiation protein 88 (MyD88) pathway favours the development of a protective T-helper (TH)1-biased T cell response. Interruption of TLR recognition or signalling has profound effects on protective immunity and enhances a TH2-biased immune response. Agonists or antagonists of specific TLRs have effects beyond infectious control and may represent a novel therapeutic for immunostimulation in vaccines, cancer, inflammatory disorders and allergy.

Related content

Toll-like receptors as therapeutic targets in gastrointestinal diseases

By Pimentel-Nunes Pedro   Soares João Bruno   Roncon-Albuquerque Jr Roberto   Dinis-Ribeiro Mário   Leite-Moreira Adelino F  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 4, 2010-04 ,pp. : 347-368 (22)

Informa Healthcare

Access to resources Recommend Favorite

Toll-like receptors as potential therapeutic targets in cardiac dysfunction

By Hofmann Ulrich   Ertl Georg   Frantz Stefan  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 6, 2011-06 ,pp. : 753-765 (13)

Informa Healthcare

Access to resources Recommend Favorite

Toll-like receptors: new therapeutic targets for autoimmune diseases

By O'Neill L.A.J.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 6, 2002-06 ,pp. : 257-257 (1)

Elsevier

Access to resources Recommend Favorite

Toll-Like Receptors and Kidney Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 191-201 (11)

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Toll-like Receptors in Autoimmunity

By  

Current Drug Targets, Vol. 10, Iss. 11, 2009-11 ,pp. : 1139-1155 (17)

Bentham Science Publishers

Access to resources Recommend Favorite